Companies & People
Ramona Optics raises $25 million to expand Durham operation
DURHAM — Ramona Optics raised $25 million to scale sales and engineering as the microscope maker moves into a larger downtown office.
NC Business Desk
Tag: life sciences
Companies & People
Raleigh’s Endpoint Clinical acquires Bluefin
RALEIGH — Raleigh-headquartered Endpoint Clinical has acquired Boston-based Bluefin, expanding its clinical-trial technology business into supply forecasting and planning.
Companies & People
Kewaunee backlog rises to $169 million as quarterly sales decline 6.7%
STATESVILLE - Kewaunee Scientific's order backlog rose to $169 million during its fiscal first quarter as sales declined 6.7% from a year earlier.
Development & Infrastructure
ABEC opens 50,000-square-foot bioprocess plant in Wilson
WILSON - ABEC has opened a 50,000-square-foot manufacturing facility that will make equipment and consumables for biologics, vaccines and other advanced medicines.
Companies & People
Labcorp buys MLM Medical Labs, expands network to four continents
BURLINGTON - Labcorp has acquired MLM Medical Labs, giving the Burlington company a wholly owned central laboratory network across North America, Europe, Asia and Africa.
Development & Infrastructure
STERIS plans $600M Sanford manufacturing hub, 335 jobs
SANFORD - STERIS plans to invest $600 million in a 600,000-square-foot manufacturing and distribution center expected to create about 335 jobs in Lee County.
Companies & People
Fortrea agrees to buy Worldwide Clinical Trials unit for $45M
DURHAM - Fortrea has agreed to pay about $45 million in cash for Worldwide Clinical Trials' early-phase services business, adding three Texas research facilities to the Durham company's…
Companies & People
Globus Medical buys Durham digital health startup
DURHAM - Globus Medical has acquired Higgs Boson Health, bringing the Duke-incubated startup's patient-engagement software and team into the medical-device company's surgical intelligence business.
Companies & People
Cape Fear BioCapital closes first fund at about $9M
DURHAM - Cape Fear BioCapital has closed its first fund at about $9 million after investing in seven North Carolina life-science companies.
Companies & People
Tenax narrows next Phase 3 trial after LEVEL misses main goal
CHAPEL HILL - Tenax Therapeutics plans to narrow enrollment in its next Phase 3 trial after TNX-103 missed the primary and key secondary endpoints in the LEVEL study,…
Companies & People
Cambrex High Point site clears path for commercial API manufacturing in three markets
HIGH POINT - The pharmaceutical manufacturer completed pre-approval inspections by U.S., Japanese and Australian regulators at its High Point facility.